Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... will be able to take advantage of a 33.50% discount price of $399 per year. Analyst’s Disclosure: I/we have ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell ...

From late 2020 to the summer of 2024, Eli Lilly ... in share price, however, investor sentiment for the next line of drugs front ran the stock price. For example, in 2016 Lilly was trading ...

President Donald Trump announced plans to sign an executive order aimed at significantly reducing U.S. prescription drug ...

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...